In this issue of Blood, Hivert et al systematically examine the acquired reduction of von Willebrand factor (VWF) activity in patients with Waldenstro ¨m macroglobulinemia (WM), but, surprisingly, they found that the high levels of VWF were a significant independent adverse prognostic factor. 1
Discussion(0)
No comments yet. Be the first to comment.